Madrid, Spain

Valentin Martinez



 

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Valentin Martinez

Introduction

Valentin Martinez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumoral agents. With a total of 3 patents to his name, his work has the potential to impact cancer treatment significantly.

Latest Patents

Martinez's latest patents include innovative compounds aimed at combating cancer. One of his notable inventions is related to antitumoral derivatives of ET-743. This patent provides derivatives of Et-743 or Et-770 or Et-729, characterized by a general formula where the substituent groups can take various permitted meanings. Another significant patent focuses on ecteinascidin analogs for use as antitumor agents. This invention details derivatives of ecteinascidin 736, which are designed to enhance the efficacy of cancer treatments.

Career Highlights

Throughout his career, Valentin Martinez has worked with prominent companies in the pharmaceutical industry, including Pharma Mar, S.A. and Pharma Mar, S.A.U. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer therapies.

Collaborations

Martinez has collaborated with several professionals in his field, including Pilar Gallego and Carmen Cuevas. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of his inventions.

Conclusion

Valentin Martinez is a distinguished inventor whose work in developing antitumoral agents showcases his commitment to advancing cancer treatment. His innovative patents and collaborations reflect his dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…